Artivion Balance Sheet Health
Financial Health criteria checks 3/6
Artivion has a total shareholder equity of $281.8M and total debt of $307.0M, which brings its debt-to-equity ratio to 108.9%. Its total assets and total liabilities are $792.4M and $510.6M respectively. Artivion's EBIT is $15.1M making its interest coverage ratio 0.6. It has cash and short-term investments of $58.9M.
Key information
108.9%
Debt to equity ratio
US$306.98m
Debt
| Interest coverage ratio | 0.6x |
| Cash | US$58.94m |
| Equity | US$281.78m |
| Total liabilities | US$510.62m |
| Total assets | US$792.40m |
Recent financial health updates
Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13
Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet
Mar 09Artivion (NYSE:AORT) Is Making Moderate Use Of Debt
Sep 29Is Artivion (NYSE:AORT) Using Too Much Debt?
Jun 27Is Artivion (NYSE:AORT) Using Too Much Debt?
Mar 25CryoLife (NYSE:CRY) Has A Somewhat Strained Balance Sheet
Dec 08Recent updates
Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13Artivion Stock: A First Assessment
Dec 27Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump
Nov 23Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025
Oct 13Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)
Jul 20Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 10Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet
Mar 09Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M
Feb 16Artivion: PROACT Xa Overhang Remains Well In Situ, Reaffirm Hold
Dec 18Artivion (NYSE:AORT) Is Making Moderate Use Of Debt
Sep 29Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver
Sep 27Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M
Aug 04Is Artivion (NYSE:AORT) Using Too Much Debt?
Jun 27Is Artivion (NYSE:AORT) Using Too Much Debt?
Mar 25CryoLife (NYSE:CRY) Has A Somewhat Strained Balance Sheet
Dec 08CryoLife, Inc. (NYSE:CRY) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 01CryoLife (NYSE:CRY) Takes On Some Risk With Its Use Of Debt
Jul 30Financial Position Analysis
Short Term Liabilities: AORT's short term assets ($280.7M) exceed its short term liabilities ($57.9M).
Long Term Liabilities: AORT's short term assets ($280.7M) do not cover its long term liabilities ($452.8M).
Debt to Equity History and Analysis
Debt Level: AORT's net debt to equity ratio (88%) is considered high.
Reducing Debt: AORT's debt to equity ratio has increased from 78.8% to 108.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AORT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AORT is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 28.5% per year.